| Product Code: ETC7920114 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Latvia`s import shipments of ranitidine in 2024 continued to be dominated by top exporters such as Ukraine, Germany, Netherlands, Spain, and the UK. Despite a high concentration of market share, the industry experienced a negative compound annual growth rate (CAGR) of -5.18% from 2020 to 2024. However, there was a significant growth spike of 355.93% from 2023 to 2024, indicating potential shifts in market dynamics and opportunities for further exploration in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Ranitidine Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Ranitidine Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Ranitidine Market - Industry Life Cycle |
3.4 Latvia Ranitidine Market - Porter's Five Forces |
3.5 Latvia Ranitidine Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Latvia Ranitidine Market Revenues & Volume Share, By Population Type, 2021 & 2031F |
3.7 Latvia Ranitidine Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 Latvia Ranitidine Market Revenues & Volume Share, By Dosage Strength, 2021 & 2031F |
3.9 Latvia Ranitidine Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Latvia Ranitidine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Ranitidine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastrointestinal disorders in Latvia |
4.2.2 Growing awareness about the effectiveness of ranitidine in treating acid-related conditions |
4.2.3 Favorable government regulations supporting the pharmaceutical industry in Latvia |
4.3 Market Restraints |
4.3.1 Stringent regulations and safety concerns related to ranitidine following recalls in various countries |
4.3.2 Competition from alternative medications and therapies for gastric issues |
4.3.3 Economic factors impacting consumer purchasing power and healthcare spending in Latvia |
5 Latvia Ranitidine Market Trends |
6 Latvia Ranitidine Market, By Types |
6.1 Latvia Ranitidine Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Latvia Ranitidine Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Latvia Ranitidine Market Revenues & Volume, By Intestinal & Stomach Ulcers, 2021- 2031F |
6.1.4 Latvia Ranitidine Market Revenues & Volume, By Gastroesophageal Reflux Disease (GERD), 2021- 2031F |
6.1.5 Latvia Ranitidine Market Revenues & Volume, By Esophagitis, 2021- 2031F |
6.1.6 Latvia Ranitidine Market Revenues & Volume, By Zollinger-Ellison Syndrome, 2021- 2031F |
6.2 Latvia Ranitidine Market, By Population Type |
6.2.1 Overview and Analysis |
6.2.2 Latvia Ranitidine Market Revenues & Volume, By Children, 2021- 2031F |
6.2.3 Latvia Ranitidine Market Revenues & Volume, By Adults, 2021- 2031F |
6.3 Latvia Ranitidine Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 Latvia Ranitidine Market Revenues & Volume, By Solid Oral, 2021- 2031F |
6.3.3 Latvia Ranitidine Market Revenues & Volume, By Liquid, 2021- 2031F |
6.3.4 Latvia Ranitidine Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Latvia Ranitidine Market, By Dosage Strength |
6.4.1 Overview and Analysis |
6.4.2 Latvia Ranitidine Market Revenues & Volume, By Oral Strength, 2021- 2031F |
6.4.3 Latvia Ranitidine Market Revenues & Volume, By Parenteral Strength, 2021- 2031F |
6.5 Latvia Ranitidine Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Latvia Ranitidine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Latvia Ranitidine Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6 Latvia Ranitidine Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Latvia Ranitidine Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.6.3 Latvia Ranitidine Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.6.4 Latvia Ranitidine Market Revenues & Volume, By online Pharmacies, 2021- 2031F |
7 Latvia Ranitidine Market Import-Export Trade Statistics |
7.1 Latvia Ranitidine Market Export to Major Countries |
7.2 Latvia Ranitidine Market Imports from Major Countries |
8 Latvia Ranitidine Market Key Performance Indicators |
8.1 Number of prescriptions for ranitidine in Latvia |
8.2 Patient satisfaction rates with ranitidine treatment |
8.3 Market penetration rate of ranitidine compared to other acid-reducing medications |
9 Latvia Ranitidine Market - Opportunity Assessment |
9.1 Latvia Ranitidine Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Latvia Ranitidine Market Opportunity Assessment, By Population Type, 2021 & 2031F |
9.3 Latvia Ranitidine Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 Latvia Ranitidine Market Opportunity Assessment, By Dosage Strength, 2021 & 2031F |
9.5 Latvia Ranitidine Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 Latvia Ranitidine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Ranitidine Market - Competitive Landscape |
10.1 Latvia Ranitidine Market Revenue Share, By Companies, 2024 |
10.2 Latvia Ranitidine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here